First AD

Second AD

Highlights of three new studies in neurology include: a new test shows promise in diagnosing multiple sclerosis (MS) quickly by identifying gene patterns in the blood, headache disorders may be a risk factor for the development of new onset hypothyroidism, and a new risk prediction scale can help in the management and decision making for patients at risk for potentially lethal malignant edema after a stroke.

Multiple Sclerosis

 multiple sclerosis (MS) clinical focus page offers information, podcasts, videos, and news about the latest study and clinical trial findings, FDA actions, clinical guideline updates, and expert interviews related to the care and management of patients with MS, including relapsing MS and progressive MS, as well as related disorders such as neuromyelitis optica spectrum disorder.

Headache and Migraine

 headache and migraine clinical focus page offers information, podcasts, videos, and news and interviews with physicians related to the care of patients with headache disorders such as chronic and episodic migraine, cluster headache, tension-type headache, and more. The page includes updates on the latest FDA actions, clinical guidelines, and study and clinical trial findings.

Stroke

 stroke clinical focus page serves as a resource for updates and information related to the clinical care and management of stroke and cerebrovascular disease, featuring news, podcasts, and videos about the latest FDA actions, clinical guideline updates, interviews with physicians, and study and clinical trial findings. The page includes information on stroke, large vessel occlusion, subcranial hemorrhage, intracranial hemorrhage, ischemic stroke, and more.

Studies include a potential test for MS, a link between headaches and hypothyroidism, and a risk prediction scale for stroke patients.

Neuro News Roundup: New MS Test & Stroke Risk